FRILIFTO Trademark

Trademark Overview

On Thursday, April 8, 2010, a trademark application was filed for FRILIFTO with the United States Patent and Trademark Office. The USPTO has given the FRILIFTO trademark a serial number of 85009747. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 8, 2013. This trademark is owned by Glaxo Group Limited. The FRILIFTO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
frilifto

General Information

Serial Number85009747
Word MarkFRILIFTO
Filing DateThursday, April 8, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 8, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 12, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 13, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, July 8, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 8, 2013ABANDONMENT - NO USE STATEMENT FILED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 24, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 23, 2012EXTENSION 4 GRANTED
Monday, October 22, 2012EXTENSION 4 FILED
Monday, October 22, 2012TEAS EXTENSION RECEIVED
Wednesday, April 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 17, 2012EXTENSION 3 GRANTED
Wednesday, April 4, 2012EXTENSION 3 FILED
Wednesday, April 4, 2012TEAS EXTENSION RECEIVED
Tuesday, November 22, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 19, 2011EXTENSION 2 GRANTED
Tuesday, November 15, 2011EXTENSION 2 FILED
Saturday, November 19, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 15, 2011TEAS EXTENSION RECEIVED
Saturday, May 14, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 12, 2011EXTENSION 1 GRANTED
Thursday, May 12, 2011EXTENSION 1 FILED
Thursday, May 12, 2011TEAS EXTENSION RECEIVED
Tuesday, December 7, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 12, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 12, 2010PUBLISHED FOR OPPOSITION
Thursday, September 9, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 9, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 8, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 8, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 8, 2010ASSIGNED TO LIE
Friday, August 20, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 14, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 14, 2010NON-FINAL ACTION E-MAILED
Wednesday, July 14, 2010NON-FINAL ACTION WRITTEN
Tuesday, July 13, 2010ASSIGNED TO EXAMINER
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 13, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 12, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

frilifto pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic